Blog

Jun 20, 2014

Availability of Biosimilar Pathways and Data/Marketing Exclusivity Globally: Update

This is an update to our post of September 27, 2013 in which we reviewed the availability of biosimilar pathways and data and/or marketing exclusivity for innovator biologics in Asia, Latin America and Eastern European countries and our post of June 4, 2014 where we reviewed the availability of biosimilar pathways and data and/or marketing […]
back to top